qz
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1?

BMY pivots to growth portfolio as legacy drugs decline, with rising new therapies helping offset revenue erosion and reshape the long-term outlook. [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Moving past speculation: How deterministic CPUs deliver predictable AI performance

For more than three decades, modern CPUs have relied on speculative execution to keep pipelines full. When it emerged in the 1990s, speculation was hailed as a breakthrough — just as pipelining and [...]

Match Score: 62.83

qz
Will Positive Camzyos Data Strengthen BMY's Cardiovascular Portfolio?

BMY's Camzyos shows strong late-stage results in adolescent heart disease, boosting hopes for expanded use as cardiovascular portfolio faces mixed developments. [...]

Match Score: 61.45

Destination
Does Cobenfy Have the Potential to Become a Top Drug for BMY?

BMY's Cobenfy gains traction with $155M in 2025 sales, outpacing peers and showing strong uptake as Bristol Myers eyes new indications and growth. [...]

Match Score: 51.30

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 33.24

Destination
Ask Engadget: How do I answer calls on my iPhone with only my voice?

Last August, my best friend asked me how she could help her neighbor set her iPhone so she could answer it without picking it up. The neighbor had Multiple Sclerosis (MS), and had lost dexterity in bo [...]

Match Score: 29.00

Destination
Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss dr [...]

Match Score: 27.70

Destination
Isomorphic Labs prepares for its first human trials with drugs designed by AlphaFold

Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.<br /> The article Isomorphic L [...]

Match Score: 27.70

Destination
Proton VPN review 2025: A nonprofit service with premium performance

Proton VPN stands out for two main reasons: it's one of the only virtual private networks (VPNs) to include a free plan with no data limits, and it's one of the few services majority-owned b [...]

Match Score: 24.20

venturebeat
Anthropic says it hit a $30 billion revenue run rate after 'crazy' 80x growth

Dario Amodei is not the kind of CEO who talks loosely about numbers. The Anthropic co-founder and chief executive, a former VP of research at OpenAI with a PhD in computational neuroscience from Princ [...]

Match Score: 23.74